IGC Pharma
IGC
#10740
Rank
NZ$37.14 M
Marketcap
NZ$0.32
Share price
-4.61%
Change (1 day)
-46.81%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Market capitalization of IGC Pharma (IGC)

Market cap: NZ$37.14 Million

As of November 2026 IGC Pharma has a market cap of NZ$37.14 Million. This makes IGC Pharma the world's 10740th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of IGC Pharma from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$37.14 M-22.75%
2025NZ$48.08 M-5.36%
2024NZ$50.81 M80%
2023NZ$28.22 M6.17%
2022NZ$26.58 M-63.57%
2021NZ$72.98 M-21.09%
2020NZ$92.5 M149.89%
2019NZ$37.01 M124.01%
2018NZ$16.52 M-58.22%
2017NZ$39.54 M244.77%
2016NZ$11.47 M91.08%
2015NZ$6 M-48.31%
2014NZ$11.61 M14.99%
2013NZ$10.1 M2.48%
2012NZ$9.85 M26.99%
2011NZ$7.76 M-39.24%
2010NZ$12.77 M-47.88%
2009NZ$24.5 M45.29%
2008NZ$16.86 M-84.33%
2007NZ$0.10 B-7.08%
2006NZ$0.11 B

End of Day market cap according to different sources

On Nov 15th, 2026 the market cap of IGC Pharma was reported to be:

NZ$37.46 Million
by Nasdaq info icon info icon
NZ$37.14 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sterling Infrastructure
STRL
NZ$16.13 B 43,327.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
NZ$4.31 B 11,526.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
NZ$9.93 B 26,657.17%๐Ÿ‡บ๐Ÿ‡ธ USA